
RNA
USDAvidity Biosciences Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$69.780
Kõrge
$69.870
Madal
$69.760
Maht
7.06M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
10.3B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
5.20M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Halper Sadeh LLC Encourages RNA, JAMF, AWK Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
TD Cowen Downgrades Avidity Biosciences to Hold, Lowers Price Target to $74
TD Cowen analyst Ritu Baral downgrades Avidity Biosciences from Buy to Hold and lowers the price target from $78 to $74.
Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders
The Ademi Firm is investigating Avidity (Nasdaq: RNA) for possible breaches of fiduciary duty and other violations of law in its transaction with...
Chardan Capital Downgrades Avidity Biosciences to Neutral, Lowers Price Target to $72
Chardan Capital analyst Keay Nakae downgrades Avidity Biosciences from Buy to Neutral and lowers the price target from $75 to $72.
RBC Capital Downgrades Avidity Biosciences to Sector Perform, Raises Price Target to $72
RBC Capital analyst Luca Issi downgrades Avidity Biosciences from Outperform to Sector Perform and raises the price target from $61 to $72.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avidity Biosciences, Inc. (NASDAQ: RNA)
Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...
Avidity Biosciences Soars After $72 Per Share Novartis Takeover
Avidity Biosciences to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.